POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals

by Medindia Content Team on July 13, 2006 at 7:05 PM
POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals

Poly Medicure Ltd today said it has applied for eight new patents and two USFDA approvals for its new range of safety syringes and safe blood collection holders.

"In our latest safety syringe, the needle retracts back in the plunger and gets locked after administering the shot so that it does not remain exposed after use. The important feature is that it cannot be reused preventing needle stick injuries," Poly Medicure Managing Director Himanshu Baid said in a release.


The company manufactures medical devices under the brand name Polymed. The safety products are used by physicians and other healthcare workers to protect themselves from stick injuries like HIV and Hepatitis A and B, the release said.

Polymed exports its products to more than 50 countries across different continents including Europe, Africa, Asia and South America, it said.

The company manufactures about 4 different products under different categories like IV Cannulaes, Infusion Therapy Devices, Central Venous Access Catheters, Anesthesia, Blood management devices and other surgical products.

Source:PTI News
Font : A-A+



Latest Drug News

Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests